S196: ROPEGINTERFERON ALFA-2B ACHIEVES PATIENT-SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD-PV/CONTINUATION-PV STUDIES

H. Gisslinger, C. Klade, P. Georgiev, D. Krochmalczyk, L. Gercheva-Kyuchukova, M. Egyed, P. Dulicek, A. Illes, H. Pylypenko, L. Sivcheva, J. Mayer, V. Yablokova, V. Empson, K. Krejcy, H. Hasselbalch, R. Kralovics, J.-J. Kiladjian

Open source

DOI: 10.1097/01.hs9.0000843676.80508.b5
Published: 2022-06
Container: HemaSphere
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/01.hs9.0000843676.80508.b5,
  title = {S196: ROPEGINTERFERON ALFA-2B ACHIEVES PATIENT-SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD-PV/CONTINUATION-PV STUDIES},
  author = {H. Gisslinger and C. Klade and P. Georgiev and D. Krochmalczyk and L. Gercheva-Kyuchukova and M. Egyed and P. Dulicek and A. Illes and H. Pylypenko and L. Sivcheva and J. Mayer and V. Yablokova and V. Empson and K. Krejcy and H. Hasselbalch and R. Kralovics and J.-J. Kiladjian},
  year = {2022},
  journal = {HemaSphere},
  doi = {10.1097/01.hs9.0000843676.80508.b5},
  url = {https://doi.org/10.1097/01.hs9.0000843676.80508.b5}
}

RIS

TY  - JOUR
TI  - S196: ROPEGINTERFERON ALFA-2B ACHIEVES PATIENT-SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD-PV/CONTINUATION-PV STUDIES
AU  - H. Gisslinger
AU  - C. Klade
AU  - P. Georgiev
AU  - D. Krochmalczyk
AU  - L. Gercheva-Kyuchukova
AU  - M. Egyed
AU  - P. Dulicek
AU  - A. Illes
AU  - H. Pylypenko
AU  - L. Sivcheva
AU  - J. Mayer
AU  - V. Yablokova
AU  - V. Empson
AU  - K. Krejcy
AU  - H. Hasselbalch
AU  - R. Kralovics
AU  - J.-J. Kiladjian
PY  - 2022
JO  - HemaSphere
DO  - 10.1097/01.hs9.0000843676.80508.b5
UR  - https://doi.org/10.1097/01.hs9.0000843676.80508.b5
ER  -

APA

Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva-Kyuchukova, L., Egyed, M., Dulicek, P., Illes, A., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Empson, V., Krejcy, K., Hasselbalch, H., Kralovics, R., & Kiladjian, J. (2022). S196: ROPEGINTERFERON ALFA-2B ACHIEVES PATIENT-SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD-PV/CONTINUATION-PV STUDIES. HemaSphere. https://doi.org/10.1097/01.hs9.0000843676.80508.b5

Source records

crossref · retrieved 2026-11-10T13:13:12.038Z